Valley National Advisers’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.78M | Buy |
44,957
+75
| +0.2% | +$8.78K | 0.64% | 32 |
|
|
2026
Q1 | $5.4M | Sell |
44,882
-26
| -0.1% | -$3K | 0.7% | 28 |
|
|
2025
Q4 | $4.73M | Sell |
44,908
-1,645
| -4% | -$154K | 0.65% | 28 |
|
|
2025
Q3 | $3.91M | Buy |
46,553
+25,843
| +125% | +$2.13M | 0.61% | 30 |
|
|
2025
Q2 | $1.64M | Buy |
20,710
+1,019
| +5% | +$81K | 0.27% | 97 |
|
|
2025
Q1 | $1.77M | Buy |
19,691
+9,111
| +86% | +$851K | 0.32% | 82 |
|
|
2024
Q4 | $1.05M | Sell |
10,580
-559
| -5% | -$57.6K | 0.19% | 121 |
|
|
2024
Q3 | $1.26M | Sell |
11,139
-10,824
| -49% | -$1.29M | 0.23% | 115 |
|
|
2024
Q2 | $2.72M | Sell |
21,963
-804
| -4% | -$104K | 0.4% | 57 |
|
|
2024
Q1 | $3M | Sell |
22,767
-80
| -0.4% | -$9.86K | 0.45% | 54 |
|
|
2023
Q4 | $2.49M | Buy |
22,847
+191
| +0.8% | +$19.8K | 0.4% | 57 |
|
|
2023
Q3 | $2.33M | Sell |
22,656
-1,042
| -4% | -$112K | 0.41% | 51 |
|
|
2023
Q2 | $2.74M | Sell |
23,698
-1,214
| -5% | -$138K | 0.46% | 46 |
|
|
2023
Q1 | $2.89M | Buy |
24,912
+1,457
| +6% | +$157K | 0.51% | 45 |
|
|
2022
Q4 | $2.6M | Sell |
23,455
-676
| -3% | -$69.1K | 0.47% | 52 |
|
|
2022
Q3 | $2.28M | Sell |
24,131
-947
| -4% | -$84.5K | 0.48% | 56 |
|
|
2022
Q2 | $2.33M | Buy |
25,078
+1,698
| +7% | +$151K | 0.49% | 52 |
|
|
2022
Q1 | $1.92M | Buy |
23,380
+8,899
| +61% | +$702K | 0.37% | 63 |
|
|
2021
Q4 | $1.11M | Buy |
14,481
+439
| +3% | +$35K | 0.2% | 110 |
|
|
2021
Q3 | $1.05M | Sell |
14,042
-208
| -1% | -$15.8K | 0.19% | 109 |
|
|
2021
Q2 | $1.11M | Sell |
14,250
-648
| -4% | -$48.2K | 0.2% | 105 |
|
|
2021
Q1 | $1.1M | Buy |
14,898
+572
| +4% | +$42.2K | 0.21% | 106 |
|
|
2020
Q4 | $1.12M | Buy |
14,326
+521
| +4% | +$39.8K | 0.23% | 94 |
|
|
2020
Q3 | $1.09M | Sell |
13,805
-1
| -0% | -$78 | 0.25% | 67 |
|
|
2020
Q2 | $1.02M | Buy |
13,806
+329
| +2% | +$24.8K | 0.23% | 73 |
|
|
2020
Q1 | $989K | Buy |
13,477
+114
| +0.9% | +$8.96K | 0.27% | 69 |
|
|
2019
Q4 | $1.16M | Buy |
13,363
+684
| +5% | +$56.2K | 0.29% | 70 |
|
|
2019
Q3 | $1.02M | Buy |
12,679
+2,334
| +23% | +$187K | 0.28% | 72 |
|
|
2019
Q2 | $828K | Sell |
10,345
-119
| -1% | -$9.11K | 0.23% | 81 |
|
|
2019
Q1 | $830K | Buy |
10,464
+93
| +0.9% | +$6.96K | 0.24% | 81 |
|
|
2018
Q4 | $756K | Sell |
10,371
-56
| -0.5% | -$3.95K | 0.25% | 80 |
|
|
2018
Q3 | $706K | Buy |
10,427
+34
| +0.3% | +$2.17K | 0.24% | 88 |
|
|
2018
Q2 | $602K | Buy |
10,393
+13
| +0.1% | +$733 | 0.23% | 95 |
|
|
2018
Q1 | $540K | Buy |
10,380
+776
| +8% | +$41.9K | 0.2% | 97 |
|
|
2017
Q4 | $516K | Sell |
9,604
-1,201
| -11% | -$66.6K | 0.18% | 100 |
|
|
2017
Q3 | $660K | Buy |
10,805
+162
| +2% | +$9.82K | 0.23% | 78 |
|
|
2017
Q2 | $651K | Hold |
10,643
| – | – | 0.23% | 74 |
|
|
2017
Q1 | $645K | Buy |
10,643
+32
| +0.3% | +$1.94K | 0.25% | 75 |
|
|
2016
Q4 | $596K | Buy |
10,611
+26
| +0.2% | +$1.52K | 0.27% | 85 |
|
|
2016
Q3 | $630K | Sell |
10,585
-596
| -5% | -$34.9K | 0.33% | 84 |
|
|
2016
Q2 | $615K | Sell |
11,181
-215
| -2% | -$11.4K | 0.32% | 85 |
|
|
2016
Q1 | $575K | Buy |
11,396
+630
| +6% | +$30.9K | 0.31% | 85 |
|
|
2015
Q4 | $543K | Buy |
10,766
+419
| +4% | +$21.1K | 0.32% | 80 |
|
|
2015
Q3 | $488K | Sell |
10,347
-211
| -2% | -$11.2K | 0.3% | 90 |
|
|
2015
Q2 | $574K | Buy |
10,558
+2,730
| +35% | +$153K | 0.32% | 85 |
|
|
2015
Q1 | $429K | Buy |
7,828
+1,179
| +18% | +$66.8K | 0.25% | 94 |
|
|
2014
Q4 | $318K | Buy |
+6,649
| New | +$370K | 0.24% | 84 |
|
Other funds holding MRK
ECSS
ATO
Valley National Advisers's MRK Position: Q2 2026 in Review
Valley National Advisers increased its Merck (MRK) stake by 0.17% in Q2 2026, buying an estimated $8.78K and bringing the position to 44,957 shares worth $5.78M. The position accounts for 0.64% of the portfolio, ranked #32.
Valley National Advisers first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Valley National Advisers held 44,957 shares of Merck worth $5.78M as of Q2 2026.
- Valley National Advisers bought 75 Merck shares in Q2 2026, an estimated $8.78K.
- Merck made up 0.64% of Valley National Advisers's portfolio in Q2 2026, its #32 holding.
- Valley National Advisers first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.